Library · reviewed November 2026

Sixteen compounds. Four evidence labels.

Sixteen of the compounds people ask about most. This is a teaching list, not a menu of products. Open any brief for what it is, what it has been studied for, and what the human record does not show. Each page has a slot for a 15-second vertical explainer.

“Studied for” describes the research question, not a proven result in people. We do not sell peptides and we do not give doses.

Human trial

Semaglutide

Target tissue
Gut–brain incretin signaling (appetite and metabolic pathways)
Studied for
Type 2 diabetes and obesity in large, published randomized trials.
Open the brief
Human trial

Tirzepatide

Target tissue
Gut–brain incretin signaling (GLP-1 and GIP pathways)
Studied for
Type 2 diabetes and obesity in large, published randomized trials.
Open the brief
Human trial

Tesamorelin

Target tissue
Visceral fat, via the growth-hormone axis
Studied for
Reducing visceral fat in a specific approved indication, with formal human trial data.
Open the brief
Human trial

SS-31

Target tissue
Mitochondrial inner membrane
Studied for
Mitochondrial membranes, as a formal rare-disease programme. Confirm the current label before treating the approval point as settled.
Open the brief
Small human study

GHK-Cu

Target tissue
Skin (collagen) and hair follicles
Studied for
Collagen, skin and hair. There is more topical and cosmetic human use than for most research peptides; large trial numbers were not extracted in our review.
Open the brief
Small human study

MOTS-c

Target tissue
Muscle mitochondria and metabolic pathways
Studied for
Exercise-mimetic metabolic signaling. The biology is strong; human intervention trials are still limited.
Open the brief
Small human study

Retatrutide

Target tissue
Metabolic signaling (GLP-1, GIP and glucagon pathways)
Studied for
Weight and metabolic outcomes as a triple agonist, in earlier-stage human trials than the approved GLP-1 medicines.
Open the brief
Small human study

CJC-1295

Target tissue
The pituitary growth-hormone axis
Studied for
Growth-hormone and IGF-1 signaling in small human studies. It is not an FDA-approved medicine, and there are no large outcome trials.
Open the brief
Small human study

Semax

Target tissue
Cortical and prefrontal networks; attention and cognition research
Studied for
Attention, focus, and brain research, mostly in Russian studies. Approved as a nasal medicine in Russia. Not FDA-approved.
Open the brief
Animal only

BPC-157

Target tissue
Tendon, ligament, muscle and the gut lining
Studied for
Tissue repair in animal models. A published human randomized trial showing faster healing has not been shown.
Open the brief
Animal only

TB-500

Target tissue
Muscle and connective tissue; proposed effects on blood-vessel growth
Studied for
Tissue repair in laboratory and animal models.
Open the brief
Animal only

Dihexa

Target tissue
Hippocampal synapses and memory research
Studied for
Memory and synapse research in animal and laboratory models. A published human trial of dihexa itself has not been shown.
Open the brief
Animal only

KPV

Target tissue
The intestinal lining and inflammatory signaling
Studied for
Gut inflammation in laboratory cells and mouse models. A published human trial has not been shown.
Open the brief
Animal only

FOXO4-DRI

Target tissue
Senescent cells in laboratory cultures and mouse aging models
Studied for
Senescent-cell and aging research in laboratory cultures and mice. A published human trial has not been shown.
Open the brief
Animal only

5-Amino-1MQ

Target tissue
Adipose and metabolic enzyme pathways. This one is a small-molecule compound, not a peptide.
Studied for
Metabolism in mice and in the lab. A published human trial has not been shown.
Open the brief
Anecdote

Pinealon

Target tissue
Brain tissue and pineal-associated research
Studied for
Sleep and neuroprotection discussions. The measured human report in our library is a single self-test of sleep staging, not a trial.
Open the brief